NEVVI Medicare utilization intelligence

← back

CHENG, JIHUAM.D. NPI 1902098544 Clinician

Hematology-Oncology · CAMP HILL, PA

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 29 years since medical school (class of 1997, self-reported to CMS)
Location CAMP HILL, PA · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 43 codes billed · 29,384 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
PENN STATE HEALTH MEDICAL GROUP LLC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2014-12

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J0897 Injection, denosumab, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
80053 Blood test, comprehensive group of blood chemicals
J1100 Injection, dexamethasone sodium phosphate, 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
96372 Injection of drug or substance under skin or into muscle
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
J7050 Infusion, normal saline solution, 250 cc
84550 Uric acid level, blood
96375 Injection of additional new drug or substance into vein
96413 Administration of chemotherapy into vein, 1 hour or less
83615 Lactate dehydrogenase (enzyme) level
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
83735 Magnesium level
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
84100 Phosphate level
96415 Administration of chemotherapy into vein, each additional hour
82565 Blood creatinine level
84520 Urea nitrogen level to assess kidney function, quantitative
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
82310 Calcium level, total
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
J7030 Infusion, normal saline solution , 1000 cc
96361 Infusion into a vein for hydration, each additional hour
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
85007 Microscopic examination for white blood cells with manual cell count
96360 Infusion into a vein for hydration, 31-60 minutes
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
81002 Urinalysis, manual test
80048 Blood test, basic group of blood chemicals (calcium, total)
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.